PAHC - フィブロ・アニマル・ヘルス (Phibro Animal Health Corporation) フィブロ・アニマル・ヘルス

 PAHCのチャート


 PAHCの企業情報

symbol PAHC
会社名 Phibro Animal Health Corp. (フィブロ・アニマル・ヘルス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 フィブロ・アニマル・ヘルス(Phibro Animal Health Corporation)は世界的な多様化した動物健康とミネラル栄養会社である。同社は動物健康、ミネラル栄養と性能製品3つの事業を含む。同社は抗菌剤、抗コクシジウム剤、ワクチン、栄養補助食品及びミネラル栄養製品などの動物用健康製品を含む多様な製品を提供する。同社はまた、パーソナルケア、自動車、工業化学および化学触媒産業で使用するための特定の原料を製造・販売する。同社の医薬品飼料添加物(MFAs)及びその他の事業は、濃縮飼料製品で構成され、動物飼料で管理される。MFAとその他の事業は、Stafac、Terramycin、Neo-TerramycinおよびMecadoxを含む抗菌剤、並びにNicarb、Aviax、Aviax Plus、Coxistacおよびamproliumを含む抗コクシジウム剤の製造・販売からなる。   フィブロ・アニマル・ヘルスは米国で動物用医薬品と栄養剤を製造、販売。「スタファック」、「エスカリン」、「Vマックス」などのブランド名で家畜用の抗生物質、抗コクシジウム剤、ワクチン、栄養剤、ミネラル剤、特殊原料を提供。大規模農場が多い米国、ブラジル中国、ロシア、オ―ストラリア、カナダなどに販売のタ―ゲットに置く。   Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce healthy, affordable food while using fewer natural resources.
本社所在地 Glenpointe Centre East 3rd Floor 300 Frank W. Burr Boulevard Suite 21 Teaneck NJ 07666-6712 USA
代表者氏名 Jack Clifford Bendheim ジャッククリフォードベンドハイム
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 201-329-7300
設立年月日
市場名 NASDAQ National Market System
ipoyear 2014年
従業員数 1500人
url www.pahc.com
nasdaq_url https://www.nasdaq.com/symbol/pahc
adr_tso
EBITDA EBITDA(百万ドル) 125.82100
終値(lastsale) 42.89
時価総額(marketcap) 1732951921.52
時価総額 時価総額(百万ドル) 1782.927
売上高 売上高(百万ドル) 819.98200
企業価値(EV) 企業価値(EV)(百万ドル) 216.14
当期純利益 当期純利益(百万ドル) 67.57500
決算概要 決算概要 BRIEF: For the fiscal year ended 30 June 2018 Phibro Animal Health Corp revenues increased 7% to $820M. Net income before extraordinary items increased 5% to $67.6M. Revenues reflect Animal Health segment increase of 7% to $531.7M Mineral Nutrition segment increase of 8% to $234.9M Latin America and Canada segment increase of 25% to $120.9M Israel segment increase of 18% to $109.2M. Net income was partially offset by Selling.

 PAHCのテクニカル分析


 PAHCのニュース

   Phibro Animal Health Corp. to Host Earnings Call  2021/02/04 12:15:00 Yahoo Finance
NEW YORK, NY / ACCESSWIRE / February 4, 2021 / Phibro Animal Health Corp. (NASDAQ:PAHC) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on February 4, 2021 at 9:00 AM Eastern Time.
   TULISSIN® 100 Brand of Tulathromycin Now Approved by Health Canada  2020/12/29 22:00:00 Business Wire
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health will represent and market Virbac’s newly approved TULISSIN® 100 brand of tulathromycin.
   Veterinary Care Market for Asia and Latin America Worth USD 23 and USD 9 billion, by 2025 - Leading Companies are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France  2020/12/16 07:24:21 OpenPR
According to the new market research report "Veterinary Care Market by Treatment Type (No medicalization, Basic Medicalization, and Under Long Term Veterinary Care), Animal Type (Dogs, Cats, Cattle, Horses, Pigs, and Poultry), and Region - Forecasts to 2025 ", published
   Global Animal Treatment Market 2020:The Next Booming Segment In The World||Leading Players-Boehringer Ingelheim International GmbH.; Elanco; Ceva; Phibro Animal Health Corporation; Abaxis  2020/12/14 09:03:02 OpenPR
Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled “Global Animal Treatment Market, By Animal Type (Dogs, Cats, Cattle, Pigs, Horses, Poultry), Treatment (No Medicalization, Basic Medicalization, Veterinary Care), Country (U.S., Canada, Mexico, Germany, Italy,
   Anti-Coccidial Drugs Market Segments, Industry News, Regional Analysis and Forecast to 2027|Global Market Player - are Impextraco NV, Vetoquinol SA, Phibro Animal Health Corporation  2020/11/18 09:09:38 OpenPR
Market Insights Global anti-coccidial drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets
   Phibro Animal Health Corp. to Host Earnings Call  2021/02/04 12:15:00 Yahoo Finance
NEW YORK, NY / ACCESSWIRE / February 4, 2021 / Phibro Animal Health Corp. (NASDAQ:PAHC) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on February 4, 2021 at 9:00 AM Eastern Time.
   TULISSIN® 100 Brand of Tulathromycin Now Approved by Health Canada  2020/12/29 22:00:00 Business Wire
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health will represent and market Virbac’s newly approved TULISSIN® 100 brand of tulathromycin.
   Veterinary Care Market for Asia and Latin America Worth USD 23 and USD 9 billion, by 2025 - Leading Companies are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France  2020/12/16 07:24:21 OpenPR
According to the new market research report "Veterinary Care Market by Treatment Type (No medicalization, Basic Medicalization, and Under Long Term Veterinary Care), Animal Type (Dogs, Cats, Cattle, Horses, Pigs, and Poultry), and Region - Forecasts to 2025 ", published
   Global Animal Treatment Market 2020:The Next Booming Segment In The World||Leading Players-Boehringer Ingelheim International GmbH.; Elanco; Ceva; Phibro Animal Health Corporation; Abaxis  2020/12/14 09:03:02 OpenPR
Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled “Global Animal Treatment Market, By Animal Type (Dogs, Cats, Cattle, Pigs, Horses, Poultry), Treatment (No Medicalization, Basic Medicalization, Veterinary Care), Country (U.S., Canada, Mexico, Germany, Italy,
   Anti-Coccidial Drugs Market Segments, Industry News, Regional Analysis and Forecast to 2027|Global Market Player - are Impextraco NV, Vetoquinol SA, Phibro Animal Health Corporation  2020/11/18 09:09:38 OpenPR
Market Insights Global anti-coccidial drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets
   Phibro Animal Health Corp. to Host Earnings Call  2021/02/04 12:15:00 Yahoo Finance
NEW YORK, NY / ACCESSWIRE / February 4, 2021 / Phibro Animal Health Corp. (NASDAQ:PAHC) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on February 4, 2021 at 9:00 AM Eastern Time.
   TULISSIN® 100 Brand of Tulathromycin Now Approved by Health Canada  2020/12/29 22:00:00 Business Wire
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health will represent and market Virbac’s newly approved TULISSIN® 100 brand of tulathromycin.
   Veterinary Care Market for Asia and Latin America Worth USD 23 and USD 9 billion, by 2025 - Leading Companies are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France  2020/12/16 07:24:21 OpenPR
According to the new market research report "Veterinary Care Market by Treatment Type (No medicalization, Basic Medicalization, and Under Long Term Veterinary Care), Animal Type (Dogs, Cats, Cattle, Horses, Pigs, and Poultry), and Region - Forecasts to 2025 ", published
   Global Animal Treatment Market 2020:The Next Booming Segment In The World||Leading Players-Boehringer Ingelheim International GmbH.; Elanco; Ceva; Phibro Animal Health Corporation; Abaxis  2020/12/14 09:03:02 OpenPR
Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled “Global Animal Treatment Market, By Animal Type (Dogs, Cats, Cattle, Pigs, Horses, Poultry), Treatment (No Medicalization, Basic Medicalization, Veterinary Care), Country (U.S., Canada, Mexico, Germany, Italy,
   Anti-Coccidial Drugs Market Segments, Industry News, Regional Analysis and Forecast to 2027|Global Market Player - are Impextraco NV, Vetoquinol SA, Phibro Animal Health Corporation  2020/11/18 09:09:38 OpenPR
Market Insights Global anti-coccidial drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets

 関連キーワード  (医薬品 米国株 フィブロ・アニマル・ヘルス PAHC Phibro Animal Health Corporation)

 twitter  (公式ツイッターやCEOツイッターなど)